GeneBioTech Co News
News
0
Ticker
086060.KQ
ISIN
KR7086060001
GeneBioTech Co Eulerpool News
GeneBioTech Co Stock News
GeneBioTech Co is being monitored by journalists and investors worldwide. We gather the latest GeneBioTech Co news here.
GeneBioTech Co Stock Press Releases
GeneBioTech Co regularly publishes news on the company's website that are relevant for investors.
GeneBioTech Co News 2026
This page contains all current news, analysis and press releases for GeneBioTech Co stock (086060.KQ, ISIN: KR7086060001). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at GeneBioTech Co.
GeneBioTech Co Stock
GeneBioTech Co GeneBioTech Co Ltd generates revenue through the production and sale of feed additives and animal drugs across two segments. The Additive segment focuses on fermented products and bio starches, while the Animal Drug segment handles livestock and fish medicine. Key products include vitamins, minerals, antibiotics, nutrients, immune stimulators, and digestion and absorption promoters. Domestic and international markets, including America, purchase these offerings. The company operates through subsidiaries, distributing its products globally. Its core business involves manufacturing and selling fermented biomass-based solutions for animal health and nutrition. Products are sold to customers in both domestic and overseas markets, with America being a key international destination. The firm's revenue streams are derived from these two primary segments and their associated product lines.